
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm?
Rosaria Vincenza Giglio, Emir Muzurović, Angelo Maria Patti, et al.
Journal of Cardiovascular Pharmacology and Therapeutics (2023) Vol. 28
Open Access | Times Cited: 6
Rosaria Vincenza Giglio, Emir Muzurović, Angelo Maria Patti, et al.
Journal of Cardiovascular Pharmacology and Therapeutics (2023) Vol. 28
Open Access | Times Cited: 6
Showing 6 citing articles:
Obicetrapib on top of maximally tolerated lipid‐modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN
Stephen J. Nicholls, Adam J. Nelson, Marc Ditmarsch, et al.
American Heart Journal (2024) Vol. 274, pp. 32-45
Open Access | Times Cited: 15
Stephen J. Nicholls, Adam J. Nelson, Marc Ditmarsch, et al.
American Heart Journal (2024) Vol. 274, pp. 32-45
Open Access | Times Cited: 15
Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies
Khamis Al-Hashmi, Rosaria Vincenza Giglio, Anca Pantea Stoian, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 9
Khamis Al-Hashmi, Rosaria Vincenza Giglio, Anca Pantea Stoian, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 9
PCSK9i promoting the transformation of AS plaques into a stable plaque by targeting the miR-186-5p/Wipf2 and miR-375-3p/Pdk1/Yap1 in ApoE−/− mice
Yanlong Zhao, Ning Liu, Jifeng Zhang, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Yanlong Zhao, Ning Liu, Jifeng Zhang, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
PCSK9 levels and diabetic retinopathy: opportunities for a potential target and novel therapeutic approach in conjunction with treating dyslipidaemia
Maria S. Varughese, Ananth Nayak, Sarita Jacob
Eye (2024)
Open Access | Times Cited: 2
Maria S. Varughese, Ananth Nayak, Sarita Jacob
Eye (2024)
Open Access | Times Cited: 2
Liver Fibrosis and Atherosclerosis, a Consequence of Metabolic Dysfunction—Do They Share a Similar Pathophysiological Background?
Emir Muzurović, Marija Maćešić, Sreten Kavarić
Angiology (2024)
Open Access | Times Cited: 1
Emir Muzurović, Marija Maćešić, Sreten Kavarić
Angiology (2024)
Open Access | Times Cited: 1
Clinical impact of genetic testing for lipid disorders
Emir Muzurović, Sanja Borozan, Manfredi Rizzo
Current Opinion in Cardiology (2024) Vol. 39, Iss. 3, pp. 154-161
Closed Access | Times Cited: 1
Emir Muzurović, Sanja Borozan, Manfredi Rizzo
Current Opinion in Cardiology (2024) Vol. 39, Iss. 3, pp. 154-161
Closed Access | Times Cited: 1